Cargando…

Cost-utility analysis of imrecoxib compared with diclofenac for patients with osteoarthritis

BACKGROUND: To estimate the cost -utility of imrecoxib compared with diclofenac, as well as the addition of a proton pump inhibitor to both two treatment strategies, for patients with osteoarthritis, from a Chinese healthcare perspective. METHODS: A Markov model was built. Costs of managing osteoart...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xueshan, Zhen, Xuemei, Hu, Xiaoqian, Li, Yuanyuan, Gu, ShuYan, Gu, Yuxuan, Zhao, Zixuan, Yang, Wei, Dong, Hengjin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056517/ https://www.ncbi.nlm.nih.gov/pubmed/33879168 http://dx.doi.org/10.1186/s12962-021-00275-7

Ejemplares similares

Osteoarthritis in the Middle-Aged and Elderly in China: Prevalence and Influencing Factors
por: Sun, Xueshan, et al.
Publicado: (2019)

Trends in Cognitive Function Among Chinese Elderly From 1998 to 2018: An Age-Period-Cohort Analysis
por: Hu, Xiaoqian, et al.
Publicado: (2021)

Trends in activities of daily living disability among Chinese older adults from 1998 to 2018: an age-period-cohort analysis
por: Hu, Xiaoqian, et al.
Publicado: (2022)

A comparative study of catastrophic health expenditure in Zhejiang and Qinghai province, China
por: Zhen, Xuemei, et al.
Publicado: (2018)

Modeling the Cost-effectiveness of Esophageal Cancer Screening in China
por: Li, Yuanyuan, et al.
Publicado: (2020)

Potential gains in health-adjusted life expectancy from reducing four main non-communicable diseases among Chinese elderly
por: Hu, Xiaoqian, et al.
Publicado: (2019)

Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis
por: Gu, Shuyan, et al.
Publicado: (2022)

The Quality of Caregivers for the Elderly in Long-Term Care Institutions in Zhejiang Province, China
por: Zeng, Yuhang, et al.
Publicado: (2019)

Clinical and economic impact of methicillin-resistant Staphylococcus aureus: a multicentre study in China
por: Zhen, Xuemei, et al.
Publicado: (2020)

Measurement and analysis of equity in health: a case study conducted in Zhejiang Province, China
por: Sun, Xueshan, et al.
Publicado: (2018)

Outpatient health-seeking behavior of residents in Zhejiang and Qinghai Province, China
por: Huang, Minzhuo, et al.
Publicado: (2019)

Comparison of Glucose-Lowering Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Gu, Shuyan, et al.
Publicado: (2022)

Social Determinants of Health-Related Quality of Life among Residents in Zhejiang and Qinghai, China
por: Gu, Yuxuan, et al.
Publicado: (2019)

Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis
por: Gu, Shuyan, et al.
Publicado: (2020)

Chinese Minority Perceives the Doctor-Patient Relationship Differently: A Cultural and Economic Interpretation
por: Yang, Qian, et al.
Publicado: (2019)

Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii: A Multicenter Study in China
por: Zhen, Xuemei, et al.
Publicado: (2020)

Imrecoxib attenuates bleomycin-induced pulmonary fibrosis in mice
por: Miao, Yang, et al.
Publicado: (2023)

Cognitive and physical function of people older than 80 years in China from 1998 to 2014
por: Hu, Xiaoqian, et al.
Publicado: (2018)

Economic burden of antibiotic resistance in China: a national level estimate for inpatients
por: Zhen, Xuemei, et al.
Publicado: (2021)

Correction to: Economic burden of antibiotic resistance in China: a national level estimate for inpatients
por: Zhen, Xuemei, et al.
Publicado: (2021)

Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China
por: Gu, Shuyan, et al.
Publicado: (2016)

Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China
por: Gu, Shuyan, et al.
Publicado: (2016)

Comparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2 Inhibitor, in Elderly Healthy Subjects
por: Yang, Ling, et al.
Publicado: (2022)

Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review
por: Zhen, Xuemei, et al.
Publicado: (2019)

The Clinical and Economic Impact of Antibiotic Resistance in China: A Systematic Review and Meta-Analysis
por: Zhen, Xuemei, et al.
Publicado: (2019)

Clinical and Economic Impact of Third-Generation Cephalosporin-Resistant Infection or Colonization Caused by Escherichia coli and Klebsiella pneumoniae: A Multicenter Study in China
por: Zhen, Xuemei, et al.
Publicado: (2020)

The Disease and Economic Burdens of Esophageal Cancer in China from 2013 to 2030: Dynamic Cohort Modeling Study
por: Li, Yuanyuan, et al.
Publicado: (2022)

A Real-World Study on the Effect of Imrecoxib for Patients with Axial Spondyloarthritis
por: Zong, He-xiang, et al.
Publicado: (2022)

The Efficacy of Imrecoxib and Celecoxib in Axial Spondyloarthritis and Their Influence on Serum Dickopff-Related Protein 1 (DKK-1) Levels
por: Gao, Guan-Min, et al.
Publicado: (2017)

Effect of multiple drug resistance on total medical costs among patients with intra-abdominal infections in China
por: Zhen, Xuemei, et al.
Publicado: (2018)

Imrecoxib Inhibits Paraquat-Induced Pulmonary Fibrosis through the NF-κB/Snail Signaling Pathway
por: Jin, Haihao
Publicado: (2020)

Lack of effect of Imrecoxib, an innovative and moderate COX-2 inhibitor, on pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers
por: Liu, Yani, et al.
Publicado: (2019)

Meta-analysis Comparing Celecoxib with Diclofenac Sodium in Patients with Knee Osteoarthritis
por: Huang, Hetao, et al.
Publicado: (2020)

Comparing Maternal Services Utilization and Expense Reimbursement before and after the Adjustment of the New Rural Cooperative Medical Scheme Policy in Rural China
por: You, Hua, et al.
Publicado: (2016)

Analgesic efficacy of imrecoxib for postoperative pain following oral surgery: a prospective randomized, active-controlled, non-inferiority trial
por: Jiang, Yu, et al.
Publicado: (2021)

Correction: Comparing Maternal Services Utilization and Expense Reimbursement Before and After the Adjustment of the New Rural Cooperative Medical Scheme Policy in Rural China
por: You, Hua, et al.
Publicado: (2017)

Comparative Effectiveness of B and E Vitamins with Diclofenac in Reducing Pain Due to Osteoarthritis of the Knee
por: Dehghan, Morteza
Publicado: (2015)

Comparative study of the effect of Thymus daenensis gel 5% and diclofenac in patients with knee osteoarthritis
por: Dehghan, Morteza, et al.
Publicado: (2019)

Efficacy and safety of combination of curcuminoid complex and diclofenac versus diclofenac in knee osteoarthritis: A randomized trial
por: Shep, Dhaneshwar, et al.
Publicado: (2020)

Cost-Effectiveness of Lung Cancer Screening Using Low-Dose Computed Tomography Based on Start Age and Interval in China: Modeling Study
por: Zhao, Zixuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nit698e3qdrshm0h2386cq7651